Clinical Effects of Lisdexamfetamine and Mixed Amphetamine Salts Immediate Release in Adult ADHD: Results of a Crossover Design Clinical Trial

References

• . Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366(9481):237–248
   PubMed Web of Science ®Google Scholar
• . Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2):187–201
   PubMed Web of Science ®Google Scholar
• . Adler LA, Chua HC. Management of ADHD in adults. J Clin Psychiatr. 2002;63( Suppl 12):29–35
   PubMed Web of Science ®Google Scholar
• . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723
   PubMed Web of Science ®Google Scholar
• . Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment, 2nd ed. New York: Guilford Press; 1998
   Google Scholar
• . Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2004;7(1):77–97
   PubMed Web of Science ®Google Scholar
• . Wilens T. Drug therapy for adults with attention-deficit hyperactivity disorder. Drugs. 2003;63(22):2395–2411
   PubMed Web of Science ®Google Scholar
• . Weisler RH, Biederman J, Spencer TJ, . Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectrums. 2006;11(8):625–639
   PubMed Web of Science ®Google Scholar
• . Spencer TJ, Adler LA, McGough JJ, . Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61(12):1380–1387
   PubMed Web of Science ®Google Scholar
• . Adler LA, Goodman DW, Kollins SH, . Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008;69(9):1364–1373
   PubMed Web of Science ®Google Scholar
• . Adler LA, Barkley RA, Newcorn JH. Performance improvement CME: adult ADHD. J Clin Psychiatry. 2011;72(4):e15
   PubMedGoogle Scholar
• . Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS. Trends in medication treatment for ADHD. J Atten Disord. 2007;10(4):335–342
   PubMedGoogle Scholar
• . Adler LA, Lynch LR, Shaw DM, . Medication adherence and symptom reduction in adults treated with mixed amphetamine salts in a randomized crossover study. Postgrad Med. 2011;123(5):71–79
   PubMed Web of Science ®Google Scholar
• . First MB, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV-TR Axis I Disorders–Patient Edition (SCID-I/P). New York: Biometrics Research Department, New York State Psychiatric Institute; 2002
   Google Scholar
• . DuPaul GJ, George J, Power TJ, Anastopoulos AD. ADHD Rating Scale—IV: Checklists, Norms, and Clinical Interpretation. New York: Guilford Press; 1998
   Google Scholar
• . Adler LA, Shaw DM, Spencer TJ, . Reliability and validity of the Time-Sensitive ADHD Symptom Scale in adults. Compr Psychiatry. 2011;52(6):769–773
   PubMed Web of Science ®Google Scholar
• . Adler LA, Shaw DM, Spencer TJ, . Preliminary reliability and validity of a new time-sensitive ADHD symptom scale in adolescents with ADHD. Postgrad Med. 2011;123(5):7–13
   PubMed Web of Science ®Google Scholar
• . Spencer TJ, Adler LA, Weisler RH, Youcha SH. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry. 2008;69(9):1437–1448
   PubMed Web of Science ®Google Scholar
• . Wender PH, Reimherr FW, Wood DR. Attention deficit disorder (“minimal brain dysfunction”) in adults. A replication study of diagnosis and drug treatment. Arch Gen Psychiatry. 1981;38(4):449–456
   PubMed Web of Science ®Google Scholar
• . Adler LA, Lynch LR, Shaw DM, . Effectiveness and duration of effect of open-label lisdexamfetamine dimesylate in adults with ADHD. J Atten Disord. 2013;8:8
   Google Scholar
• . Roth RM, Isquith PK, Gioia GA. BRIEF—A Behavior Rating Inventory of Executive Function—Adult Version, Publication Manual. Lutz, FL: Psychological Assessment Resources, Inc.; 2005
   Google Scholar
• . Guy W. Clinical global impressions. In: Guy W, ed. ECDEU Assessment Manual for Psychopharmacology (Revised). Rockville, MD: National Institute of Mental Health; 1976:217–221
   Google Scholar
• . Winhusen TM, Somoza EC, Brigham GS, . Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2010;71(12):1680–1688
   PubMed Web of Science ®Google Scholar
• . Adler LA, Zimmerman B, Starr HL, . Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, doseescalation study. J Clin Psychopharmacol. 2009;29(3):239–247
   PubMed Web of Science ®Google Scholar
• . Adler LA, Spencer T, Faraone SV, . Training raters to assess adult ADHD: reliability of ratings. J Atten Disord. 2005;8(3):121–126
   PubMedGoogle Scholar
• . Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213
   PubMed Web of Science ®Google Scholar
• . Adler LA, Dirks B, Deas PF, . Lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2013;74(7):694–702
   PubMed Web of Science ®Google Scholar
• . Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010;122(1):184–191
   PubMed Web of Science ®Google Scholar
• . Weisler R, Young J, Mattingly G, Gao J, Squires L, Adler L. Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. CNS Spectr. 2009;14(10):573–585
   PubMed Web of Science ®Google Scholar
• . Durell TM, Adler LA, Williams DW, . Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol. 2013;33(1):45–54
   PubMed Web of Science ®Google Scholar
• . Adler L, Tanaka Y, Williams D, . Executive function in adults with attention-deficit/hyperactivity disorder during treatment with atomoxetine in a randomized, placebo-controlled, withdrawal study. J Clin Psychopharmacol. 2014;34(4):461–466
   PubMed Web of Science ®Google Scholar